Menu
FDA-Approved, Insurance-Covered, and Easy to Use
SPRAVATO® is covered by most major insurance plans, and we’ll handle the paperwork to make the process as seamless as possible.
Clinically proven and FDA-approved for treatment-resistant depression, offering new hope for those who haven’t found relief.
A simple, guided nasal spray treatment administered in a safe and supportive environment.
SPRAVATO® (esketamine) is a groundbreaking nasal spray treatment specifically designed for individuals struggling with treatment-resistant depression. FDA-approved and clinically proven, Spravato works differently than traditional antidepressants, offering rapid relief for patients who have not responded to other treatments.
With SPRAVATO®, patients experience hope and healing through a safe and carefully monitored process guided by our experienced care team.
65% of TRD patients respond positively to SPRAVATO® within 6 weeks
7% chance of success with trying a 4th medication* (*STAR-D trial)
SPRAVATO® is a fast-acting nasal spray designed to target treatment-resistant depression at its core. Unlike traditional antidepressants that take weeks or months to show results, SPRAVATO® works by directly interacting with the brain’s NMDA receptors, helping to restore connections and reduce depressive symptoms rapidly.
Administered in a safe and supervised environment, SPRAVATO® treatments are closely monitored by our experienced care team to ensure your comfort and well-being. Most patients begin to feel relief within hours or days, offering a transformative path to healing.
We believe that mental health care should be accessible to everyone. That’s why SPRAVATO® treatments at our clinic are covered by most major insurance providers. Our team works directly with your insurance company to make the process seamless, so you can focus on your well-being without worrying about the paperwork.
We accept:
Begin with a complimentary phone consultation, followed by an in-depth evaluation by our mental health professionals. This includes reviewing your medical history and treatment needs to confirm eligibility for SPRAVATO®. If eligible, we verify your insurance coverage, working with major providers to ensure a hassle-free process.
Once you’re approved, we handle the insurance process on your behalf, removing the complexity so you can focus on your mental health journey.
Your initial SPRAVATO® session is scheduled. Treatments are administered in our clinic under strict medical supervision. You self-administer the nasal spray in a calm, controlled environment and are monitored for at least two hours to ensure safety and address any side effects.
Your treatment plan begins with an induction phase, typically involving twice-weekly sessions. Over time, this transitions to a maintenance phase with less frequent treatments customized to your unique mental health goals.
Our team remains by your side throughout your journey, offering regular follow-ups to monitor progress and address concerns. We adjust your treatment plan as needed, coordinate with your referring provider, and ensure you have the resources for sustained mental health improvement.
Week 1-4
2 Treatments a Week
Week 5-8
1 Treatments a Week
Week 9+
1 Treatment a Week Every 1-2 Weeks
Rediscover Relief When You Need it Most with This Easy-to-Use Treatment
70% Efficacy of SPRAVATO®
70% of patients treated with SPRAVATO® showed a 50% reduction in depressive symptoms on the Montgomery-Asberg Depression Rating Scale (MADRS) by the end of 4 weeks.
40% Rapid Onset of Relief
40% of patients experienced a noticeable reduction in depressive symptoms within 24 hours of the first dose of SPRAVATO®.
51% Long-Term Care
51% of patients maintained remission from depressive symptoms after continuing SPRAVATO® in a long-term study.
SPRAVATO® represents a groundbreaking advance in the treatment of depression, especially for individuals who have not found relief through traditional antidepressants. Its unique mechanism targeting the glutamate system provides a new avenue for rapid relief, meeting an urgent need in the field of mental health.
SPRAVATO®, or esketamine, is a prescription nasal spray for adults with treatment-resistant depression (TRD) or major depressive disorder (MDD) with suicidal thoughts. Approved by the FDA in 2019, it works differently from traditional antidepressants by targeting the NMDA receptors in the brain, which influence mood and neural plasticity. This unique approach can provide relief within hours or days, offering a rapid response for those who haven’t found success with other antidepressants.
Administered under medical supervision due to side effects like dizziness and dissociation, SPRAVATO® is used alongside an oral antidepressant. The treatment begins with twice-weekly doses, which may taper off as patients stabilize. Due to its potential for misuse, it is dispensed only in certified healthcare settings under the FDA’s REMS program, ensuring controlled and safe usage.
Ready to prioritize your mental health? Reach out to KHC today for insurance verification. Our experienced team will guide you through the process, ensuring you possess the necessary information to make informed decisions for your well-being.
Don’t let insurance complexities hinder your path to the treatment you deserve.
Contact us now to embark on a journey towards a happier and healthier life.
Disclaimer: Insurance coverage varies based on individual plans and policies. While SPRAVATO®-assisted ketamine therapy may be covered by insurance, it’s important to confirm the details of your specific coverage with our team and your insurance provider.
Ketamine Haven Clinic is dedicated to offering advanced mental health treatments with a focus on ketamine therapy. Our expert team provides compassionate, personalized care to help individuals overcome depression, anxiety, PTSD, and chronic pain. We are committed to innovative, holistic approaches that empower our patients to achieve lasting wellness and improved quality of life.
Hours
© 2025 Ketamine Haven Clinic. All Rights Reserved.
